Vitamin Shoppe (VSI) Cut to “Hold” at Zacks Investment Research

Zacks Investment Research cut shares of Vitamin Shoppe (NYSE:VSI) from a buy rating to a hold rating in a research note published on Wednesday.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

A number of other equities analysts have also recently issued reports on the stock. Morgan Stanley began coverage on shares of Vitamin Shoppe in a research report on Monday, September 17th. They set an equal weight rating and a $14.00 price objective for the company. ValuEngine raised shares of Vitamin Shoppe from a buy rating to a strong-buy rating in a report on Tuesday, September 4th. Finally, Barclays lowered shares of Vitamin Shoppe from an equal weight rating to an underweight rating in a report on Friday, September 7th.

VSI stock opened at $9.08 on Wednesday. The company has a market cap of $242.69 million, a P/E ratio of 23.28 and a beta of 0.75. Vitamin Shoppe has a 1 year low of $2.95 and a 1 year high of $13.95. The company has a quick ratio of 0.32, a current ratio of 1.96 and a debt-to-equity ratio of 0.32.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, August 8th. The specialty retailer reported $0.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.27. The business had revenue of $293.10 million during the quarter, compared to analysts’ expectations of $279.87 million. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%.

In other Vitamin Shoppe news, Director Guillermo Marmol bought 8,900 shares of Vitamin Shoppe stock in a transaction on Friday, August 10th. The shares were purchased at an average cost of $11.21 per share, with a total value of $99,769.00. Following the acquisition, the director now directly owns 49,479 shares of the company’s stock, valued at approximately $554,659.59. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sharon M. Leite bought 5,500 shares of Vitamin Shoppe stock in a transaction on Friday, August 31st. The shares were acquired at an average cost of $12.64 per share, for a total transaction of $69,520.00. Following the completion of the acquisition, the chief executive officer now directly owns 5,500 shares in the company, valued at $69,520. The disclosure for this purchase can be found here. Insiders own 18.50% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of VSI. Schwab Charles Investment Management Inc. boosted its stake in shares of Vitamin Shoppe by 29.4% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 863,237 shares of the specialty retailer’s stock valued at $3,756,000 after purchasing an additional 196,125 shares during the last quarter. California Public Employees Retirement System boosted its stake in shares of Vitamin Shoppe by 5.0% in the 1st quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock valued at $1,230,000 after purchasing an additional 13,338 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Vitamin Shoppe by 10.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock valued at $7,288,000 after purchasing an additional 158,123 shares during the last quarter. GSA Capital Partners LLP bought a new stake in shares of Vitamin Shoppe in the 1st quarter valued at $109,000. Finally, Millennium Management LLC bought a new stake in shares of Vitamin Shoppe in the 1st quarter valued at $1,628,000. 89.53% of the stock is currently owned by hedge funds and other institutional investors.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Featured Article: Day Trading

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply